CoChat

Effectiveness of combined therapy with pirfenidone and inhaled N‐acetylcysteine for advanced idiopathic pulmonary fibrosis: A case–control study

Sakamoto, Susumu, Muramatsu, Yoko, Satoh, Keita, Ishida, Fumiaki, Kikuchi, Naoshi, Sano, Go, Sugino, Keishi, Isobe, Kazutoshi, Takai, Yujiro, Homma, Sakae · 2015 · Respirology
Cited by 70

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background and objective: Treatment with pirfenidone may slow the decline in vital capacity and increase progression‐free survival (PFS) in idiopathic pulmonary fibrosis (IPF). The effects of combination therapy with inhaled N‐acetylcysteine (NAC) and pirfenidone are unclear. We assessed the effects of this combination therapy in patients with advanced IPF. Methods: Patients with a diagnosis of advanced IPF(J apanese R espiratory S ociety stage III/IV IPF) and a relative decline in forced vital capacity (FVC) of ≥10% within the previous 6 (±2) months were enrolled. Outcomes were evaluated in a 12‐month follow‐up pulmonary function test. Treatment was considered ineffective if the decline in FVC was ≥10% and effective if the decline was <10%. We compared clinical characteristics, effectiveness and PFS between patients receiving inhaled NAC plus pirfenidone (n = 24) and those receiving pirfenidone alone (control;n = 10). Results: Data from 34 IPF patients (age range, 59–82 years) were analysed. At the 12‐month follow‐up examination, treatment was deemed effective in 8 of 17 (47%) patients receiving NAC plus pirfenidone and in 2 of 10 (20%) receiving pirfenidone alone. The annual rate of change in FVC was −610 mL in the NAC plus pirfenidone group and −1320 mL in the pirfenidone group (P < 0.01). PFS was longer (304 days) in the NAC plus pirfenidone group than in the pirfenidone group (168 days;P = 0.016). Conclusions: Combination treatment with inhaled NAC and oral pirfenidone reduced the rate of annual FVC decline and improved PFS in patients with advanced IPF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/resp.12477

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 70

Metadata

Authors
Sakamoto, S., Muramatsu, Y., Satoh, K., Ishida, F., Kikuchi, N., Sano, G., Sugino, K., Isobe, K., Takai, Y., & Homma, S.
Venue
Respirology
Publisher
Wiley
Published
2015-02-02
Volume
20
Issue
3
Pages
445-452
ISSN
  • 1323-7799 (ISSN-L)
  • 1440-1843
OpenAlex
W1708007155
Cited by
70
References
6
FWCI
5.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of combined therapy with pirfenidone and inhaled N‐acetylcysteine for advanced idiopathic pulmonary fibrosis: A case–control study. https://app.cochat.ai/papers/10.1111/resp.12477
The paper
Sakamoto, S., Muramatsu, Y., Satoh, K., Ishida, F., Kikuchi, N., Sano, G., Sugino, K., Isobe, K., Takai, Y., & Homma, S. (2015). Effectiveness of combined therapy with pirfenidone and inhaled N‐acetylcysteine for advanced idiopathic pulmonary fibrosis: A case–control study. Respirology. https://doi.org/10.1111/resp.12477

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.